SCHEMBL819794

SCHEMBL819794

C=C(C)C(=O)Oc1ccc(C(C)CC)cc1

nearest known ligand 0.54

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.54
TSHR P16473 2/20 0.54
ELANE P08246 1/20 0.50
KMT2A Q03164 3/20 0.47
ATM Q13315 1/20 0.47
MEN1 O00255 1/20 0.46
TDP1 Q9NUW8 1/20 0.46
ESR1 P03372 1/20 0.45
HIF1A Q16665 1/20 0.45
NPC1 O15118 2/20 0.44
RAB9A P51151 2/20 0.44
MAPT P10636 2/20 0.42
GAA P10253 1/20 0.42
HSP90AA1 P07900 1/20 0.42
L3MBTL1 Q9Y468 1/20 0.42
NPSR1 Q6W5P4 1/20 0.40
SMN1; SMN2 Q16637 2/20 0.40
LMNA P02545 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13784594 0.88 ELANE (0.48) ALDH1A1TSHRELANEKMT2AATM
SCHEMBL22074734 0.87 ELANE (0.50) ALDH1A1TSHRELANEKMT2AATM
SCHEMBL3087898 0.86 ESR1 (0.50) ALDH1A1TSHRELANEKMT2AATM
SCHEMBL4122942 0.85 ELANE (0.55) ALDH1A1TSHRELANEKMT2AATM
SCHEMBL13784596 0.85 ELANE (0.46) ALDH1A1TSHRELANEKMT2AATM
SCHEMBL25784257 0.83 TSHR (0.45) ALDH1A1TSHRELANEKMT2AMEN1
SCHEMBL12286433 0.83 ALDH1A1 (0.51) ALDH1A1TSHRKMT2AMEN1TDP1
SCHEMBL4594842 0.83 ELANE (0.56) ALDH1A1ELANEKMT2AATMMEN1
SCHEMBL111718 0.83 TSHR (0.60) ALDH1A1TSHRELANEKMT2AMEN1
SCHEMBL15221808 0.81 ELANE (0.54) ALDH1A1TSHRELANEKMT2AATM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 69 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1740235-B1 COATING COMPOSITIONS FOR BIOACTIVE AGENTS SURMODICS INC (US) 2009-07-22 EP claimed
US-7544673-B2 Coating compositions for bioactive agents SURMODICS, INC. (US) 2009-06-09 US claimed
US-7541048-B2 Coating compositions for bioactive agents SURMODICS, INC. (US) 2009-06-02 US claimed
JP-2007532187-A 2007-11-15 JP claimed
EP-1740235-A1 COATING COMPOSITIONS FOR BIOACTIVE AGENTS SurModics, Inc. (US) 2007-01-10 EP claimed
US-20050244459-A1 Coating compositions for bioactive agents Surmodics Coatings, LLC 2005-11-03 US claimed
WO-2005099787-A1 COATING COMPOSITIONS FOR BIOACTIVE AGENTS SURMODICS, INC. (US) 2005-10-27 WO claimed
WO-2005099786-A1 COATING COMPOSITIONS FOR BIOACTIVE AGENTS SURMODICS, INC. (US) 2005-10-27 WO claimed
US-20050220840-A1 Coating compositions for bioactive agents Surmodics Coatings, LLC 2005-10-06 US claimed
US-20050220841-A1 Coating compositions for bioactive agents Surmodics Coatings, LLC 2005-10-06 US claimed
US-20050220843-A1 Coating compositions for bioactive agents Surmodics Coatings, LLC 2005-10-06 US claimed
US-20050220839-A1 Coating compositions for bioactive agents Surmodics Coatings, LLC 2005-10-06 US claimed
US-20050220842-A1 Coating compositions for bioactive agents Surmodics Coatings, LLC 2005-10-06 US claimed
US-9726798-B2 Optical film, polarizing plate, and method for producing optical film FUJIFILM CORPORATION (JP) 2017-08-08 US disclosed
EP-2265293-B1 COATING SYSTEMS FOR THE CONTROLLED DELIVERY OF HYDROPHILIC BIOACTIVE AGENTS SURMODICS INC (US) 2015-11-04 EP disclosed
US-20150277006-A1 OPTICAL FILM, POLARIZING PLATE, AND METHOD FOR PRODUCING OPTICAL FILM FUJIFILM CORPORATION (JP) 2015-10-01 US disclosed
US-20050220840-A1 Coating compositions for bioactive agents Surmodics Coatings, LLC 2005-10-06 US disclosed
US-20050220841-A1 Coating compositions for bioactive agents Surmodics Coatings, LLC 2005-10-06 US disclosed
US-20050220843-A1 Coating compositions for bioactive agents Surmodics Coatings, LLC 2005-10-06 US disclosed
US-20050220839-A1 Coating compositions for bioactive agents Surmodics Coatings, LLC 2005-10-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050220839-A1 Coating compositions for bioactive agents BMP2, FGF23, TGFB1 ALDH1A1 4304/4885TSHR 3995/4885ELANE 257/4885
US-20050220841-A1 Coating compositions for bioactive agents BMP2, FGF23, TGFB1 ALDH1A1 4304/4885TSHR 3995/4885ELANE 257/4885
US-20050220843-A1 Coating compositions for bioactive agents BMP2, FGF23, TGFB1 ALDH1A1 4304/4885TSHR 3995/4885ELANE 257/4885
US-20050220842-A1 Coating compositions for bioactive agents BMP2, FGF23, TGFB1 ALDH1A1 4304/4885TSHR 3995/4885ELANE 257/4885
US-20050220840-A1 Coating compositions for bioactive agents BMP2, FGF23, TGFB1 ALDH1A1 4304/4885TSHR 3995/4885ELANE 257/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.